However, RE treatment markedly enhanced the expression of DRP1, MFN2, and FIS1 in the skeletal muscle of T2DM-RE mice compared to T2DM-SED mice (Figure 4C–F). This evidence concerns the gene MFN2 and type 2 diabetes mellitus.